Opsens Inc.
Get $10 bonus on your first $100 deposit for OPSSF
Get $10 bonus on your first $100 deposit for OPSSF
Opsens Inc. (OPSSF) Stock Competitors & Peer Comparison
See (OPSSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OPSSF | $2.14 | +0.65% | 247.4M | -26.74 | -$0.08 | N/A |
| SRTOY | $20.41 | +2.15% | 201.7B | 64.80 | $0.32 | +0.21% |
| MECNY | $88.63 | +0.00% | 107.5B | N/A | N/A | N/A |
| ESLOY | $116.43 | +0.00% | 106.8B | 40.89 | $2.84 | +1.94% |
| ESLOF | $229.94 | -0.25% | 106.5B | 39.44 | $5.83 | +1.96% |
| SOAGY | $51.06 | +2.00% | 74.8B | 98.50 | $0.52 | +0.18% |
| HOCPY | $186.62 | +0.23% | 62.8B | 48.66 | $3.83 | +0.68% |
| HOCPF | $179.27 | +8.65% | 60.4B | 46.81 | $3.83 | +0.94% |
| RSMDF | $24.89 | +26.60% | 36.3B | 24.64 | $1.01 | +1.02% |
| TRUMY | $13.63 | +1.26% | 20B | 24.20 | $0.56 | +1.32% |
Stock Comparison
OPSSF vs SRTOY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SRTOY has a market cap of 201.7B. Regarding current trading prices, OPSSF is priced at $2.14, while SRTOY trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SRTOY's P/E ratio is 64.80. In terms of profitability, OPSSF's ROE is -0.36%, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SRTOY's competition here
OPSSF vs MECNY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, MECNY has a market cap of 107.5B. Regarding current trading prices, OPSSF is priced at $2.14, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas MECNY's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, OPSSF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check MECNY's competition here
OPSSF vs ESLOY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ESLOY has a market cap of 106.8B. Regarding current trading prices, OPSSF is priced at $2.14, while ESLOY trades at $116.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ESLOY's P/E ratio is 40.89. In terms of profitability, OPSSF's ROE is -0.36%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ESLOY's competition here
OPSSF vs ESLOF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ESLOF has a market cap of 106.5B. Regarding current trading prices, OPSSF is priced at $2.14, while ESLOF trades at $229.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ESLOF's P/E ratio is 39.44. In terms of profitability, OPSSF's ROE is -0.36%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ESLOF's competition here
OPSSF vs SOAGY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SOAGY has a market cap of 74.8B. Regarding current trading prices, OPSSF is priced at $2.14, while SOAGY trades at $51.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SOAGY's P/E ratio is 98.50. In terms of profitability, OPSSF's ROE is -0.36%, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SOAGY's competition here
OPSSF vs HOCPY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, HOCPY has a market cap of 62.8B. Regarding current trading prices, OPSSF is priced at $2.14, while HOCPY trades at $186.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas HOCPY's P/E ratio is 48.66. In terms of profitability, OPSSF's ROE is -0.36%, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, OPSSF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check HOCPY's competition here
OPSSF vs HOCPF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, HOCPF has a market cap of 60.4B. Regarding current trading prices, OPSSF is priced at $2.14, while HOCPF trades at $179.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas HOCPF's P/E ratio is 46.81. In terms of profitability, OPSSF's ROE is -0.36%, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, OPSSF is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check HOCPF's competition here
OPSSF vs RSMDF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, RSMDF has a market cap of 36.3B. Regarding current trading prices, OPSSF is priced at $2.14, while RSMDF trades at $24.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas RSMDF's P/E ratio is 24.64. In terms of profitability, OPSSF's ROE is -0.36%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, OPSSF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check RSMDF's competition here
OPSSF vs TRUMY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TRUMY has a market cap of 20B. Regarding current trading prices, OPSSF is priced at $2.14, while TRUMY trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TRUMY's P/E ratio is 24.20. In terms of profitability, OPSSF's ROE is -0.36%, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, OPSSF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TRUMY's competition here
OPSSF vs SDMHF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SDMHF has a market cap of 19.9B. Regarding current trading prices, OPSSF is priced at $2.14, while SDMHF trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SDMHF's P/E ratio is 65.08. In terms of profitability, OPSSF's ROE is -0.36%, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, OPSSF is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SDMHF's competition here
OPSSF vs TRUMF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TRUMF has a market cap of 18.3B. Regarding current trading prices, OPSSF is priced at $2.14, while TRUMF trades at $12.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TRUMF's P/E ratio is 22.55. In terms of profitability, OPSSF's ROE is -0.36%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, OPSSF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TRUMF's competition here
OPSSF vs SAUHY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SAUHY has a market cap of 17.3B. Regarding current trading prices, OPSSF is priced at $2.14, while SAUHY trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SAUHY's P/E ratio is 38.71. In terms of profitability, OPSSF's ROE is -0.36%, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, OPSSF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SAUHY's competition here
OPSSF vs SUVPF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SUVPF has a market cap of 16.9B. Regarding current trading prices, OPSSF is priced at $2.14, while SUVPF trades at $244.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SUVPF's P/E ratio is 94.40. In terms of profitability, OPSSF's ROE is -0.36%, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SUVPF's competition here
OPSSF vs SAUHF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SAUHF has a market cap of 16.7B. Regarding current trading prices, OPSSF is priced at $2.14, while SAUHF trades at $104.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SAUHF's P/E ratio is 37.48. In terms of profitability, OPSSF's ROE is -0.36%, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, OPSSF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SAUHF's competition here
OPSSF vs SARTF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SARTF has a market cap of 15.6B. Regarding current trading prices, OPSSF is priced at $2.14, while SARTF trades at $226.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SARTF's P/E ratio is 87.72. In terms of profitability, OPSSF's ROE is -0.36%, compared to SARTF's ROE of +0.06%. Regarding short-term risk, OPSSF is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SARTF's competition here
OPSSF vs CLPBY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CLPBY has a market cap of 15.1B. Regarding current trading prices, OPSSF is priced at $2.14, while CLPBY trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CLPBY's P/E ratio is 23.95. In terms of profitability, OPSSF's ROE is -0.36%, compared to CLPBY's ROE of +0.25%. Regarding short-term risk, OPSSF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CLPBY's competition here
OPSSF vs SSSGY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SSSGY has a market cap of 13.6B. Regarding current trading prices, OPSSF is priced at $2.14, while SSSGY trades at $39.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SSSGY's P/E ratio is 75.87. In terms of profitability, OPSSF's ROE is -0.36%, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SSSGY's competition here
OPSSF vs CLPBF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CLPBF has a market cap of 13.5B. Regarding current trading prices, OPSSF is priced at $2.14, while CLPBF trades at $65.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CLPBF's P/E ratio is 23.66. In terms of profitability, OPSSF's ROE is -0.36%, compared to CLPBF's ROE of +0.25%. Regarding short-term risk, OPSSF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CLPBF's competition here
OPSSF vs FSPKF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, FSPKF has a market cap of 13.5B. Regarding current trading prices, OPSSF is priced at $2.14, while FSPKF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas FSPKF's P/E ratio is 52.32. In terms of profitability, OPSSF's ROE is -0.36%, compared to FSPKF's ROE of +0.30%. Regarding short-term risk, OPSSF is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check FSPKF's competition here
OPSSF vs OCPNF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, OCPNF has a market cap of 10.5B. Regarding current trading prices, OPSSF is priced at $2.14, while OCPNF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas OCPNF's P/E ratio is 17.59. In terms of profitability, OPSSF's ROE is -0.36%, compared to OCPNF's ROE of +0.11%. Regarding short-term risk, OPSSF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check OCPNF's competition here
OPSSF vs CNVVY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CNVVY has a market cap of 6.1B. Regarding current trading prices, OPSSF is priced at $2.14, while CNVVY trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CNVVY's P/E ratio is 36.68. In terms of profitability, OPSSF's ROE is -0.36%, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, OPSSF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CNVVY's competition here
OPSSF vs CNVVF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CNVVF has a market cap of 5.7B. Regarding current trading prices, OPSSF is priced at $2.14, while CNVVF trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CNVVF's P/E ratio is 32.33. In terms of profitability, OPSSF's ROE is -0.36%, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, OPSSF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CNVVF's competition here
OPSSF vs SSMXY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SSMXY has a market cap of 5.5B. Regarding current trading prices, OPSSF is priced at $2.14, while SSMXY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SSMXY's P/E ratio is 18.64. In terms of profitability, OPSSF's ROE is -0.36%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, OPSSF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SSMXY's competition here
OPSSF vs AHICF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, AHICF has a market cap of 5.4B. Regarding current trading prices, OPSSF is priced at $2.14, while AHICF trades at $20.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas AHICF's P/E ratio is 48.50. In terms of profitability, OPSSF's ROE is -0.36%, compared to AHICF's ROE of +0.12%. Regarding short-term risk, OPSSF is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check AHICF's competition here
OPSSF vs SSMXF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SSMXF has a market cap of 5.3B. Regarding current trading prices, OPSSF is priced at $2.14, while SSMXF trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SSMXF's P/E ratio is 17.94. In terms of profitability, OPSSF's ROE is -0.36%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, OPSSF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SSMXF's competition here
OPSSF vs ADDLF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, OPSSF is priced at $2.14, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, OPSSF's ROE is -0.36%, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, OPSSF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ADDLF's competition here
OPSSF vs YPHDF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, OPSSF is priced at $2.14, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas YPHDF's P/E ratio is 19.76. In terms of profitability, OPSSF's ROE is -0.36%, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, OPSSF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check YPHDF's competition here
OPSSF vs FLMNF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, OPSSF is priced at $2.14, while FLMNF trades at $50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas FLMNF's P/E ratio is 20.06. In terms of profitability, OPSSF's ROE is -0.36%, compared to FLMNF's ROE of +0.20%. Regarding short-term risk, OPSSF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check FLMNF's competition here
OPSSF vs FLMNY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, OPSSF is priced at $2.14, while FLMNY trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas FLMNY's P/E ratio is 19.87. In terms of profitability, OPSSF's ROE is -0.36%, compared to FLMNY's ROE of +0.20%. Regarding short-term risk, OPSSF is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check FLMNY's competition here
OPSSF vs ANSLF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ANSLF has a market cap of 3.3B. Regarding current trading prices, OPSSF is priced at $2.14, while ANSLF trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, OPSSF's ROE is -0.36%, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, OPSSF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check ANSLF's competition here
OPSSF vs ANSLY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, OPSSF is priced at $2.14, while ANSLY trades at $83.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ANSLY's P/E ratio is 22.45. In terms of profitability, OPSSF's ROE is -0.36%, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, OPSSF is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ANSLY's competition here
OPSSF vs CZMWY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CZMWY has a market cap of 2.7B. Regarding current trading prices, OPSSF is priced at $2.14, while CZMWY trades at $30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CZMWY's P/E ratio is 16.44. In terms of profitability, OPSSF's ROE is -0.36%, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, OPSSF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CZMWY's competition here
OPSSF vs CZMWF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CZMWF has a market cap of 2.7B. Regarding current trading prices, OPSSF is priced at $2.14, while CZMWF trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CZMWF's P/E ratio is 16.42. In terms of profitability, OPSSF's ROE is -0.36%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, OPSSF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CZMWF's competition here
OPSSF vs SHWGY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SHWGY has a market cap of 2.5B. Regarding current trading prices, OPSSF is priced at $2.14, while SHWGY trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SHWGY's P/E ratio is 10.95. In terms of profitability, OPSSF's ROE is -0.36%, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, OPSSF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SHWGY's competition here
OPSSF vs TCGGY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, OPSSF is priced at $2.14, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, OPSSF's ROE is -0.36%, compared to TCGGY's ROE of -0.09%. Regarding short-term risk, OPSSF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TCGGY's competition here
OPSSF vs EKTAF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, EKTAF has a market cap of 2.3B. Regarding current trading prices, OPSSF is priced at $2.14, while EKTAF trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas EKTAF's P/E ratio is -620.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to EKTAF's ROE of -0.00%. Regarding short-term risk, OPSSF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check EKTAF's competition here
OPSSF vs EKTAY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, EKTAY has a market cap of 2.3B. Regarding current trading prices, OPSSF is priced at $2.14, while EKTAY trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas EKTAY's P/E ratio is -590.80. In terms of profitability, OPSSF's ROE is -0.36%, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, OPSSF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check EKTAY's competition here
OPSSF vs SHWGF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, OPSSF is priced at $2.14, while SHWGF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SHWGF's P/E ratio is 9.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, OPSSF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SHWGF's competition here
OPSSF vs TCHBF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TCHBF has a market cap of 2B. Regarding current trading prices, OPSSF is priced at $2.14, while TCHBF trades at $156.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TCHBF's P/E ratio is -14.26. In terms of profitability, OPSSF's ROE is -0.36%, compared to TCHBF's ROE of -0.09%. Regarding short-term risk, OPSSF is more volatile compared to TCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check TCHBF's competition here
OPSSF vs BOEUF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, OPSSF is priced at $2.14, while BOEUF trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas BOEUF's P/E ratio is 108.52. In terms of profitability, OPSSF's ROE is -0.36%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, OPSSF is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check BOEUF's competition here
OPSSF vs NPRRF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, OPSSF is priced at $2.14, while NPRRF trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas NPRRF's P/E ratio is 26.92. In terms of profitability, OPSSF's ROE is -0.36%, compared to NPRRF's ROE of N/A. Regarding short-term risk, OPSSF is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check NPRRF's competition here
OPSSF vs TGLVY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TGLVY has a market cap of 1.6B. Regarding current trading prices, OPSSF is priced at $2.14, while TGLVY trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TGLVY's P/E ratio is 39.55. In terms of profitability, OPSSF's ROE is -0.36%, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, OPSSF is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TGLVY's competition here
OPSSF vs SAFLY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SAFLY has a market cap of 1.3B. Regarding current trading prices, OPSSF is priced at $2.14, while SAFLY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SAFLY's P/E ratio is 16.22. In terms of profitability, OPSSF's ROE is -0.36%, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, OPSSF is more volatile compared to SAFLY. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SAFLY's competition here
OPSSF vs BITGF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, OPSSF is priced at $2.14, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas BITGF's P/E ratio is 45.50. In terms of profitability, OPSSF's ROE is -0.36%, compared to BITGF's ROE of +0.04%. Regarding short-term risk, OPSSF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check BITGF's competition here
OPSSF vs PBHDF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, OPSSF is priced at $2.14, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, OPSSF's ROE is -0.36%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, OPSSF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check PBHDF's competition here
OPSSF vs TDVXF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TDVXF has a market cap of 1B. Regarding current trading prices, OPSSF is priced at $2.14, while TDVXF trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TDVXF's P/E ratio is 61.25. In terms of profitability, OPSSF's ROE is -0.36%, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, OPSSF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TDVXF's competition here
OPSSF vs SAFLF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SAFLF has a market cap of 906.6M. Regarding current trading prices, OPSSF is priced at $2.14, while SAFLF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SAFLF's P/E ratio is 16.50. In terms of profitability, OPSSF's ROE is -0.36%, compared to SAFLF's ROE of +0.12%. Regarding short-term risk, OPSSF is more volatile compared to SAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SAFLF's competition here
OPSSF vs NNCSF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, NNCSF has a market cap of 849.5M. Regarding current trading prices, OPSSF is priced at $2.14, while NNCSF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas NNCSF's P/E ratio is 56.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, OPSSF is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check NNCSF's competition here
OPSSF vs KSRBF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, KSRBF has a market cap of 841.7M. Regarding current trading prices, OPSSF is priced at $2.14, while KSRBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, OPSSF's ROE is -0.36%, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, OPSSF is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check KSRBF's competition here
OPSSF vs HGYMF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, OPSSF is priced at $2.14, while HGYMF trades at $34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, OPSSF's ROE is -0.36%, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, OPSSF is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check HGYMF's competition here
OPSSF vs GRRMF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, GRRMF has a market cap of 713.3M. Regarding current trading prices, OPSSF is priced at $2.14, while GRRMF trades at $20.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas GRRMF's P/E ratio is 26.14. In terms of profitability, OPSSF's ROE is -0.36%, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, OPSSF is less volatile compared to GRRMF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check GRRMF's competition here
OPSSF vs JNDOF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, OPSSF is priced at $2.14, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, OPSSF's ROE is -0.36%, compared to JNDOF's ROE of +0.29%. Regarding short-term risk, OPSSF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check JNDOF's competition here
OPSSF vs SPMXF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, OPSSF is priced at $2.14, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to SPMXF's ROE of -0.07%. Regarding short-term risk, OPSSF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check SPMXF's competition here
OPSSF vs CLHLF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, OPSSF is priced at $2.14, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, OPSSF's ROE is -0.36%, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, OPSSF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check CLHLF's competition here
OPSSF vs GUERF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, OPSSF is priced at $2.14, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas GUERF's P/E ratio is 8.19. In terms of profitability, OPSSF's ROE is -0.36%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, OPSSF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check GUERF's competition here
OPSSF vs TSNLF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TSNLF has a market cap of 249.2M. Regarding current trading prices, OPSSF is priced at $2.14, while TSNLF trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TSNLF's P/E ratio is 24.76. In terms of profitability, OPSSF's ROE is -0.36%, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, OPSSF is more volatile compared to TSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check TSNLF's competition here
OPSSF vs EEOIF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, OPSSF is priced at $2.14, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, OPSSF's ROE is -0.36%, compared to EEOIF's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check EEOIF's competition here
OPSSF vs OTCFF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, OTCFF has a market cap of 21.2M. Regarding current trading prices, OPSSF is priced at $2.14, while OTCFF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas OTCFF's P/E ratio is -13.22. In terms of profitability, OPSSF's ROE is -0.36%, compared to OTCFF's ROE of +1.24%. Regarding short-term risk, OPSSF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check OTCFF's competition here
OPSSF vs UEEC Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, UEEC has a market cap of 14.3M. Regarding current trading prices, OPSSF is priced at $2.14, while UEEC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas UEEC's P/E ratio is -2.76. In terms of profitability, OPSSF's ROE is -0.36%, compared to UEEC's ROE of +1.00%. Regarding short-term risk, OPSSF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check UEEC's competition here
OPSSF vs BLMHF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, OPSSF is priced at $2.14, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, OPSSF's ROE is -0.36%, compared to BLMHF's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check BLMHF's competition here
OPSSF vs PXMVF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, OPSSF is priced at $2.14, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, OPSSF's ROE is -0.36%, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, OPSSF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check PXMVF's competition here
OPSSF vs CBSC Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CBSC has a market cap of 4.5M. Regarding current trading prices, OPSSF is priced at $2.14, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CBSC's P/E ratio is -4.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to CBSC's ROE of +0.58%. Regarding short-term risk, OPSSF is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check CBSC's competition here
OPSSF vs MCDA Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, OPSSF is priced at $2.14, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas MCDA's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to MCDA's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check MCDA's competition here
OPSSF vs GVDI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, GVDI has a market cap of 4.2M. Regarding current trading prices, OPSSF is priced at $2.14, while GVDI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas GVDI's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, OPSSF is more volatile compared to GVDI. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check GVDI's competition here
OPSSF vs RSCF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, RSCF has a market cap of 3.8M. Regarding current trading prices, OPSSF is priced at $2.14, while RSCF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas RSCF's P/E ratio is -4.42. In terms of profitability, OPSSF's ROE is -0.36%, compared to RSCF's ROE of +0.10%. Regarding short-term risk, OPSSF is more volatile compared to RSCF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check RSCF's competition here
OPSSF vs NSTGQ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, OPSSF is priced at $2.14, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, OPSSF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check NSTGQ's competition here
OPSSF vs TUTH Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TUTH has a market cap of 2.4M. Regarding current trading prices, OPSSF is priced at $2.14, while TUTH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TUTH's P/E ratio is -0.95. In terms of profitability, OPSSF's ROE is -0.36%, compared to TUTH's ROE of +0.27%. Regarding short-term risk, OPSSF is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TUTH's competition here
OPSSF vs ECIA Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ECIA has a market cap of 1.6M. Regarding current trading prices, OPSSF is priced at $2.14, while ECIA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ECIA's P/E ratio is -4.33. In terms of profitability, OPSSF's ROE is -0.36%, compared to ECIA's ROE of -0.22%. Regarding short-term risk, OPSSF is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check ECIA's competition here
OPSSF vs YBGJ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, YBGJ has a market cap of 1.1M. Regarding current trading prices, OPSSF is priced at $2.14, while YBGJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas YBGJ's P/E ratio is -0.95. In terms of profitability, OPSSF's ROE is -0.36%, compared to YBGJ's ROE of +0.38%. Regarding short-term risk, OPSSF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check YBGJ's competition here
OPSSF vs OJSY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, OPSSF is priced at $2.14, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas OJSY's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to OJSY's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check OJSY's competition here
OPSSF vs PDMI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, OPSSF is priced at $2.14, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas PDMI's P/E ratio is -0.01. In terms of profitability, OPSSF's ROE is -0.36%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, OPSSF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check PDMI's competition here
OPSSF vs WHSI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, OPSSF is priced at $2.14, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas WHSI's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, OPSSF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check WHSI's competition here
OPSSF vs BLFE Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, OPSSF is priced at $2.14, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas BLFE's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to BLFE's ROE of +3.67%. Regarding short-term risk, OPSSF is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check BLFE's competition here
OPSSF vs CEOS Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, CEOS has a market cap of 127.8K. Regarding current trading prices, OPSSF is priced at $2.14, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas CEOS's P/E ratio is -0.01. In terms of profitability, OPSSF's ROE is -0.36%, compared to CEOS's ROE of +0.40%. Regarding short-term risk, OPSSF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check CEOS's competition here
OPSSF vs QTXB Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, OPSSF is priced at $2.14, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas QTXB's P/E ratio is -0.05. In terms of profitability, OPSSF's ROE is -0.36%, compared to QTXB's ROE of +0.19%. Regarding short-term risk, OPSSF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check QTXB's competition here
OPSSF vs IMTH Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, IMTH has a market cap of 89.8K. Regarding current trading prices, OPSSF is priced at $2.14, while IMTH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas IMTH's P/E ratio is -0.03. In terms of profitability, OPSSF's ROE is -0.36%, compared to IMTH's ROE of -0.60%. Regarding short-term risk, OPSSF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check IMTH's competition here
OPSSF vs LANZ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, LANZ has a market cap of 74.5K. Regarding current trading prices, OPSSF is priced at $2.14, while LANZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas LANZ's P/E ratio is 2.70. In terms of profitability, OPSSF's ROE is -0.36%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, OPSSF is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check LANZ's competition here
OPSSF vs GMVDF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, OPSSF is priced at $2.14, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas GMVDF's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, OPSSF is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check GMVDF's competition here
OPSSF vs REMI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, REMI has a market cap of 14K. Regarding current trading prices, OPSSF is priced at $2.14, while REMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas REMI's P/E ratio is -0.07. In terms of profitability, OPSSF's ROE is -0.36%, compared to REMI's ROE of -0.11%. Regarding short-term risk, OPSSF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check REMI's competition here
OPSSF vs SDCCQ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SDCCQ has a market cap of 13.4K. Regarding current trading prices, OPSSF is priced at $2.14, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, OPSSF is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SDCCQ's competition here
OPSSF vs MDIT Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, OPSSF is priced at $2.14, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas MDIT's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, OPSSF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check MDIT's competition here
OPSSF vs ASFX Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ASFX has a market cap of 7K. Regarding current trading prices, OPSSF is priced at $2.14, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ASFX's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, OPSSF is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ASFX's competition here
OPSSF vs DGEN Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, OPSSF is priced at $2.14, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas DGEN's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, OPSSF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check DGEN's competition here
OPSSF vs SVSO Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, OPSSF is priced at $2.14, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SVSO's P/E ratio is -0.01. In terms of profitability, OPSSF's ROE is -0.36%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, OPSSF is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SVSO's competition here
OPSSF vs LFPI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, OPSSF is priced at $2.14, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas LFPI's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, OPSSF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check LFPI's competition here
OPSSF vs INND Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, INND has a market cap of 1.2K. Regarding current trading prices, OPSSF is priced at $2.14, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas INND's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to INND's ROE of +0.09%. Regarding short-term risk, OPSSF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check INND's competition here
OPSSF vs SEYE Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, OPSSF is priced at $2.14, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SEYE's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to SEYE's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SEYE's competition here
OPSSF vs BGMD Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, OPSSF is priced at $2.14, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas BGMD's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to BGMD's ROE of +7.47%. Regarding short-term risk, OPSSF is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check BGMD's competition here
OPSSF vs ADLI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, OPSSF is priced at $2.14, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas ADLI's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, OPSSF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check ADLI's competition here
OPSSF vs VSMD Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, VSMD has a market cap of 802. Regarding current trading prices, OPSSF is priced at $2.14, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas VSMD's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, OPSSF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check VSMD's competition here
OPSSF vs TEVNF Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, OPSSF is priced at $2.14, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas TEVNF's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, OPSSF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check TEVNF's competition here
OPSSF vs HRAL Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, HRAL has a market cap of 396. Regarding current trading prices, OPSSF is priced at $2.14, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas HRAL's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to HRAL's ROE of +0.21%. Regarding short-term risk, OPSSF is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for OPSSF.Check HRAL's competition here
OPSSF vs MICRD Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, MICRD has a market cap of 317. Regarding current trading prices, OPSSF is priced at $2.14, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas MICRD's P/E ratio is -0.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, OPSSF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check MICRD's competition here
OPSSF vs RGBOQ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, OPSSF is priced at $2.14, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check RGBOQ's competition here
OPSSF vs SECI Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, SECI has a market cap of 31. Regarding current trading prices, OPSSF is priced at $2.14, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas SECI's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to SECI's ROE of -0.00%. Regarding short-term risk, OPSSF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check SECI's competition here
OPSSF vs VTEQ Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, OPSSF is priced at $2.14, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, OPSSF's ROE is -0.36%, compared to VTEQ's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check VTEQ's competition here
OPSSF vs MEDVD Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, OPSSF is priced at $2.14, while MEDVD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas MEDVD's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to MEDVD's ROE of N/A. Regarding short-term risk, OPSSF is more volatile compared to MEDVD. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check MEDVD's competition here
OPSSF vs OCPNY Comparison April 2026
OPSSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OPSSF stands at 247.4M. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, OPSSF is priced at $2.14, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OPSSF currently has a P/E ratio of -26.74, whereas OCPNY's P/E ratio is N/A. In terms of profitability, OPSSF's ROE is -0.36%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, OPSSF is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for OPSSF.Check OCPNY's competition here